Atara Biotherapeutics Inc (NASDAQ: ATRA) is -50.64% lower on its value in year-to-date trading and has touched a low of $6.50 and a high of $39.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ATRA stock was last observed hovering at around $7.83 in the last trading session, with the day’s loss setting it -1.26%.
Currently trading at $6.57, the stock is -49.83% and -46.37% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.93 million and changing -16.09% at the moment leaves the stock -42.54% off its SMA200. ATRA registered -63.25% loss for a year compared to 6-month gain of -37.46%. The firm has a 50-day simple moving average (SMA 50) of $12.2511 and a 200-day simple moving average (SMA200) of $11.435.
The stock witnessed a -37.49% loss in the last 1 month and extending the period to 3 months gives it a -28.59%, and is -57.75% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 27.17% over the week and 15.97% over the month.
Atara Biotherapeutics Inc (ATRA) has around 225 employees, a market worth around $37.84M and $100.44M in sales. Profit margin for the company is -132.58%. Distance from 52-week low is 1.08% and -83.37% from its 52-week high.
with sales reaching $24.3M over the same period.The EPS is expected to grow by 85.95% this year, but quarterly earnings will post 1,332.31% year-over-year. Quarterly sales are estimated to grow 471.44% in year-over-year returns.
Atara Biotherapeutics Inc (ATRA) Top Institutional Holders
67.0 institutions hold shares in Atara Biotherapeutics Inc (ATRA), with institutional investors hold 65.29% of the company’s shares. The shares outstanding are 5.74M, and float is at 4.31M with Short Float at 12.38%. Institutions hold 50.82% of the Float.
The top institutional shareholder in the company is BOXER CAPITAL, LLC with over 0.17 million shares valued at $1.41 million. The investor’s holdings represent 0.1181% of the ATRA Shares outstanding. As of 2024-06-30, the second largest holder is LAKE STREET ADVISORS GROUP, LLC with 11000.0 shares valued at $93500.0 to account for 0.0078 of the shares outstanding. The other top investors are IFP ADVISORS, INC which holds 4500.0 shares representing 0.0032% and valued at over $1756.0, while CWM, LLC holds 0.0004 of the shares totaling 542.0 with a market value of $5000.0.
Atara Biotherapeutics Inc (ATRA) Insider Activity
The most recent transaction is an insider sale by Henrich Jill, the company’s EVP, Chief Regulatory Officer. SEC filings show that Henrich Jill sold 1,000 shares of the company’s common stock on Nov 18 ’24 at a price of $11.20 per share for a total of $11198.0. Following the sale, the insider now owns 19378.0 shares.
Atara Biotherapeutics Inc disclosed in a document filed with the SEC on Nov 18 ’24 that Hyllengren Eric J (EVP, CFO and COO) sold a total of 1,364 shares of the company’s common stock. The trade occurred on Nov 18 ’24 and was made at $11.20 per share for $15274.0. Following the transaction, the insider now directly holds 23392.0 shares of the ATRA stock.
Still, SEC filings show that on Nov 18 ’24, Nguyen AnhCo (President and CEO) disposed off 1,664 shares at an average price of $11.20 for $18633.0. The insider now directly holds 77,454 shares of Atara Biotherapeutics Inc (ATRA).
